Story thread · 2 reports / 2 sources
PTC Therapeutics, Lilly to buy up bits of Sangamo in bankruptcy auction
endpts.com · 10h · first report
The bankrupt gene editing biotech Sangamo is set to sell chunks of its business to PTC Therapeutics and Eli Lilly for up to $264 million following an auction procedure. Sangamo said ...
The coverage
- PTC Therapeutics’ $211M Bid Wins Bankruptcy Auction for Sangamo Gene Therapy
medcitynews.com · 2h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.